Co-trimoxazole in cases of gram-negative septicaemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001442:Bacteroides Infections / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000139:chemically induced; D014295:Trimethoprim / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole